On Friday, Sunedison Inc (NYSE:SUNE)’s shares inclined 0.09% to $11.27.
SunEdison, Inc. (SUNE), the largest global renewable energy development company, in partnership with BITHENERGY, a leading solar developer, recently declared that Columbia, Md. is now offsetting 100 percent of its energy use from renewable sources. Columbia now sources 75 percent of its energy from wind renewable energy credits, and 25 percent from a newly accomplished two megawatt (MW) DC solar farm in SunEdison and BITHENERGY’s Nixon Farm solar project in West Friendship, Md.
The 2 MW solar farm is predictable to generate enough energy to power more than 250 homes and avoid the emission of more than two million pounds of carbon dioxide, equivalent to taking 220 cars off the road.
Columbia, Md. is home to about 100,000 people, and is managed by the non-profit service corporation Columbia Association. The non-profit is purchasing the solar power for the community through a 20 year power purchase agreement with SunEdison. The solar farm is located outside of Columbia, and via virtual net metering credits the community can enjoy the benefits of solar without the need to locate the solar farm on-site.
SunEdison, Inc. develops, manufactures, and sells silicon wafers to the semiconductor industry. The company operates through three segments: Solar Energy, TerraForm Power, and Semiconductor Materials. The Solar Energy segment provides solar energy services that integrate the design, installation, financing, monitoring, operations, and maintenance portions of the downstream solar market. It also manufactures polysilicon, silicon wafers, and solar modules. As of December 31, 2014, this segment had interconnected about 974 solar power systems representing 2.35 gigawatts of solar energy generating capacity. The TerraForm Power Segment owns and operates clean power generation assets that sell electricity through long-term power purchase agreements to utility, commercial, and residential customers.
Mastercard Inc (NYSE:MA)’s shares gained 1.90% to $91.38.
Millions of MasterCard cardholders will soon have even more ways to make safe and convenient mobile payments. Recently, Google declared that they are starting to roll out Android Pay in the U.S., enabling seamless and secure contactless payments at millions of locations across the country where MasterCard contactless payments are accepted.
Over the next few days, owners of eligible Android devices can start using Android Pay. For those consumers who receive automatic updates to their Android devices, the Google Wallet app will automatically update to Android Pay. Those who don’t receive automatic updates can download the Android Pay app from the Google Play Store in the next few days. Consumers can add their MasterCard credit, debit, select small business and prepaid cards from participating banks.
MasterCard Incorporated, a technology company, provides transaction processing and other payment-related products and services in the United States and internationally. The company facilitates the processing of payment transactions, counting authorization, clearing, and settlement, in addition to delivers related products and services. It also offers value-added services, such as loyalty and reward programs, and information and consulting services.
At the end of Friday’s trade, ZS Pharma Inc (NASDAQ:ZSPH)‘s shares surged 3.02% to $76.99.
ZS Pharma, Inc. (ZSPH), confirmed that it has take partd in preliminary talk about with Actelion Ltd. (ALIOF) regarding a potential planned transaction. ZS Pharma regularly and routinely explores opportunities with various planned partners and will continue to do so. These talk about may or may not lead to any transaction. ZS Pharma does not intend to comment further on market speculation or disclose any developments unless and until it otherwise deems further disclosure is appropriate or required.
ZS Pharma, Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of non-absorbed drugs to treat renal, cardiovascular, liver, and metabolic diseases. The company’s proprietary zirconium silicate technology creates ion traps that could reduce toxic levels of specific electrolytes without disturbing the balance of other electrolytes. It is developing ZS-9, insoluble non-absorbed zirconium silicate that is in Phase III development for the treatment of hyperkalemia. The company was founded in 2008 and is headquartered in Coppell, Texas.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
